13D/A filed by GOLDENTREE ASSET MANAGEMENT LP
GOLDENTREE ASSET MANAGEMENT LP and 2 other reporting persons reported 8,442,827 shares of Keenova Therapeutics plc, 21.3% of the class, as of 2026-09-24, in a 13D/A accepted by EDGAR 2026-10-06 20:30:09 UTC.
- Accession
- 0001493152-26-045957
- Filer
- CIK 1278951
- Filed
- 2026-10-06
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- Keenova Therapeutics plc
- Shares
- 8,442,827
- Percent of class
- 21.3%
- Event date
- 2026-09-24
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group GOLDENTREE ASSET MANAGEMENT LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| GoldenTree Asset Management LP | PN | 0 | 8,389,212 | 0 | 8,389,212 | 8,389,212 | 21.2% |
| GoldenTree Asset Management LLC | OO | 0 | 8,389,212 | 0 | 8,389,212 | 8,389,212 | 21.2% |
| Steven A. Tananbaum | IN | 53,615 | 8,389,212 | 53,615 | 8,389,212 | 8,442,827 | 21.3% |